Higher level of IL-6 in Jaccoud’s arthropathy secondary to systemic lupus erythematosus: a perspective for its treatment?

Jaccoud’s arthropathy (JA) is a condition characterized clinically by ‘reversible’ joint deformities along with an absence of articular erosions on a plain radiograph. The main clinical entity associated with JA is systemic lupus erythematosus (SLE) with a prevalence of around 5 %. The aim of the pr...

Full description

Saved in:

Bibliographic Details
Published in:	Rheumatology international Vol. 35; no. 1; pp. 167 - 170
Main Authors:	Atta, Ajax Mercês, Oliveira, Rodrigo C., Oliveira, Isabela S., Menezes, Mariana P., Santos, Taciana P. S., Sousa Atta, Maria Luiza B., Santiago, Mittermayer B.
Format:	Journal Article
Language:	English
Published:	Berlin/Heidelberg Springer Berlin Heidelberg 01-01-2015 Springer Nature B.V
Subjects:	Adult Biomarkers - blood Cytokines - blood Female Humans Interleukin-6 - blood Joint Diseases - blood Joint Diseases - etiology Lupus Erythematosus, Systemic - blood Lupus Erythematosus, Systemic - complications Medicine Medicine & Public Health Middle Aged Original Article Rheumatology Systemic lupus erythematosus Cytokines Jaccoud’s arthropathy Interleukin-6
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Jaccoud’s arthropathy (JA) is a condition characterized clinically by ‘reversible’ joint deformities along with an absence of articular erosions on a plain radiograph. The main clinical entity associated with JA is systemic lupus erythematosus (SLE) with a prevalence of around 5 %. The aim of the present study was to compare the inflammatory markers including cytokine levels in blood of SLE patients with and without JA. Patients with diagnosis of SLE as defined by ACR criteria were screened and divided in two groups, one with JA and one control group without JA. Erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), complement C3 and C4 levels antinuclear antibodies (ANA), anti-dsDNA antibodies and serum levels of IL-2, IL-6, IL-10, IL-21, IL-22 and TNF-α were determined in all patients. Eighty female patients with SLE, 18 (22.5 %) with JA and 62 (77.5 %) without JA, were included in this study. JA patients had higher disease duration ( p = 0.008), ESR ( p < 0.001), CRP level ( p = 0.002), ANA titer ( p < 0.001) and dsDNA antibody level ( p = 0.009). The serum levels of IL-2, IL-10, IL-21, IL-22 and TNF-α were not significantly different between the two groups ( p > 0.05), but the level of IL-6 was higher in JA group ( p < 0.001). The serum level of IL-6 might have a correlation with JA secondary to SLE.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	0172-8172 1437-160X
DOI:	10.1007/s00296-014-3069-0